big potential hereAnalysts are saying this'll go to 14 clams within a yr, min 5.
this implies guaranteed moooola baby.
they got this
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.29 USD
−65.77 M USD
24.35 M USD
17.94 M
About Aadi Bioscience, Inc.
Sector
Industry
CEO
David Lennon
Website
Headquarters
Los Angeles
Founded
2007
FIGI
BBG002WN7DT2
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Los Angeles, CA.
AADI - NASDAQ PENNY Biotech pre-earnings LONGAADI has earnings in two day. On the 30 minute chart, it is significantly below the highs of May
and June where it was in a wide ranged consolidation. After that in July price trended down
along the support of the second lower VWAP line into a reversal on August 1 shich also
ascended the VWAP
AADI longTrade levels are:
Entry price: $12.53
Take profit: $14.04
Stop loss: $11.96
Risk/reward: 2,65
AADI - DOUBLE BOTTOMpotentially a double bottom where we could bounce in one of the 2 areas - i would like to see bull divergence and accumulation before going long
Projection of this target as shown.
Finally hit Entry on $AADIAs you can see, $AADI hit on the Support line at 18.62.
I set my Targets at:
21.64
25.78
27.80
and expect a gain around 50%.
AADI Technical analyse.As you can see, $AADI is in a down Channel.
As I said before, we bounce off the channel down resistance line and will most likely touch the support line, after which we can definitely expect a breakout from the channel down. However, I am not sure if we will bounce off Resistance Line 2 or expect a
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AADI is 2.13 USD — it has increased by 1.19% in the past 24 hours. Watch Aadi Bioscience, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aadi Bioscience, Inc. stocks are traded under the ticker AADI.
AADI stock has risen by 6.78% compared to the previous week, the month change is a 8.42% rise, over the last year Aadi Bioscience, Inc. has showed a −54.30% decrease.
We've gathered analysts' opinions on Aadi Bioscience, Inc. future price: according to them, AADI price has a max estimate of 2.00 USD and a min estimate of 1.75 USD. Watch AADI chart and read a more detailed Aadi Bioscience, Inc. stock forecast: see what analysts think of Aadi Bioscience, Inc. and suggest that you do with its stocks.
AADI reached its all-time high on Sep 18, 2017 with the price of 101.25 USD, and its all-time low was 1.21 USD and was reached on Aug 8, 2024. View more price dynamics on AADI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AADI stock is 4.53% volatile and has beta coefficient of 0.27. Track Aadi Bioscience, Inc. stock price on the chart and check out the list of the most volatile stocks — is Aadi Bioscience, Inc. there?
Today Aadi Bioscience, Inc. has the market capitalization of 52.38 M, it has increased by 0.51% over the last week.
Yes, you can track Aadi Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
Aadi Bioscience, Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
AADI earnings for the last quarter are −0.46 USD per share, whereas the estimation was −0.46 USD resulting in a −0.55% surprise. The estimated earnings for the next quarter are −0.31 USD per share. See more details about Aadi Bioscience, Inc. earnings.
Aadi Bioscience, Inc. revenue for the last quarter amounts to 7.21 M USD, despite the estimated figure of 6.59 M USD. In the next quarter, revenue is expected to reach 7.27 M USD.
AADI net income for the last quarter is −12.55 M USD, while the quarter before that showed −14.58 M USD of net income which accounts for 13.97% change. Track more Aadi Bioscience, Inc. financial stats to get the full picture.
No, AADI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 11, 2024, the company has 89.00 employees. See our rating of the largest employees — is Aadi Bioscience, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aadi Bioscience, Inc. EBITDA is −63.39 M USD, and current EBITDA margin is −294.67%. See more stats in Aadi Bioscience, Inc. financial statements.
Like other stocks, AADI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aadi Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aadi Bioscience, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aadi Bioscience, Inc. stock shows the sell signal. See more of Aadi Bioscience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.